carcinotech ltd
carcinotech ltd Company Information
Company Number
SC604026
Website
-Registered Address
roslin innovation centre, easter bush campus, edinburgh, midlothian, EH25 9RG
Industry
Research and experimental development on biotechnology
Telephone
-
Next Accounts Due
June 2025
Group Structure
View All
Shareholders
ishani malhotra 29.2%
scottish enterprise 20.4%
View Allcarcinotech ltd Estimated Valuation
Pomanda estimates the enterprise value of CARCINOTECH LTD at £863.1k based on a Turnover of £854k and 1.01x industry multiple (adjusted for size and gross margin).
carcinotech ltd Estimated Valuation
Pomanda estimates the enterprise value of CARCINOTECH LTD at £0 based on an EBITDA of £-531.9k and a 4.15x industry multiple (adjusted for size and gross margin).
carcinotech ltd Estimated Valuation
Pomanda estimates the enterprise value of CARCINOTECH LTD at £267.9k based on Net Assets of £522.2k and 0.51x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Carcinotech Ltd Overview
Carcinotech Ltd is a live company located in edinburgh, EH25 9RG with a Companies House number of SC604026. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in July 2018, it's largest shareholder is ishani malhotra with a 29.2% stake. Carcinotech Ltd is a young, small sized company, Pomanda has estimated its turnover at £854k with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Carcinotech Ltd Health Check
Pomanda's financial health check has awarded Carcinotech Ltd a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
6 Weak
Size
annual sales of £854k, make it smaller than the average company (£3.5m)
- Carcinotech Ltd
£3.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 52%, show it is growing at a faster rate (12%)
- Carcinotech Ltd
12% - Industry AVG
Production
with a gross margin of 25.6%, this company has a higher cost of product (53.5%)
- Carcinotech Ltd
53.5% - Industry AVG
Profitability
an operating margin of -62.3% make it less profitable than the average company (-1.1%)
- Carcinotech Ltd
-1.1% - Industry AVG
Employees
with 9 employees, this is below the industry average (43)
9 - Carcinotech Ltd
43 - Industry AVG
Pay Structure
on an average salary of £75.4k, the company has an equivalent pay structure (£75.4k)
- Carcinotech Ltd
£75.4k - Industry AVG
Efficiency
resulting in sales per employee of £94.9k, this is less efficient (£125.8k)
- Carcinotech Ltd
£125.8k - Industry AVG
Debtor Days
it gets paid by customers after 214 days, this is later than average (53 days)
- Carcinotech Ltd
53 days - Industry AVG
Creditor Days
its suppliers are paid after 116 days, this is slower than average (60 days)
- Carcinotech Ltd
60 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Carcinotech Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Carcinotech Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 35.3%, this is a lower level of debt than the average (52.9%)
35.3% - Carcinotech Ltd
52.9% - Industry AVG
CARCINOTECH LTD financials
Carcinotech Ltd's latest turnover from September 2023 is estimated at £854 thousand and the company has net assets of £522.2 thousand. According to their latest financial statements, Carcinotech Ltd has 9 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | |
|---|---|---|---|---|---|
| Turnover | |||||
| Other Income Or Grants | |||||
| Cost Of Sales | |||||
| Gross Profit | |||||
| Admin Expenses | |||||
| Operating Profit | |||||
| Interest Payable | |||||
| Interest Receivable | |||||
| Pre-Tax Profit | |||||
| Tax | |||||
| Profit After Tax | |||||
| Dividends Paid | |||||
| Retained Profit | |||||
| Employee Costs | |||||
| Number Of Employees | 9 | 5 | 3 | 1 | |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | |
|---|---|---|---|---|---|
| Tangible Assets | 199,980 | 169,792 | 44,898 | 39,262 | 299 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 199,980 | 169,792 | 44,898 | 39,262 | 299 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 501,692 | 1,038,385 | 70,332 | 138,796 | 9,871 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 105,853 | 30,020 | 13,877 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 |
| total current assets | 607,545 | 1,068,405 | 84,209 | 138,796 | 9,871 |
| total assets | 807,525 | 1,238,197 | 129,107 | 178,058 | 10,170 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 203,678 | 119,797 | 83,595 | 112,817 | 13,002 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 203,678 | 119,797 | 83,595 | 112,817 | 13,002 |
| loans | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 81,686 | 64,352 | 44,483 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 81,686 | 64,352 | 44,483 | 0 | 0 |
| total liabilities | 285,364 | 184,149 | 128,078 | 112,817 | 13,002 |
| net assets | 522,161 | 1,054,048 | 1,029 | 65,241 | -2,832 |
| total shareholders funds | 522,161 | 1,054,048 | 1,029 | 65,241 | -2,832 |
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Operating Profit | |||||
| Depreciation | |||||
| Amortisation | |||||
| Tax | |||||
| Stock | 0 | 0 | 0 | 0 | 0 |
| Debtors | -460,860 | 984,196 | -54,587 | 128,925 | 9,871 |
| Creditors | 83,881 | 36,202 | -29,222 | 99,815 | 13,002 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||
| Investing Activities | |||||
| capital expenditure | |||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||
| Financing Activities | |||||
| Bank loans | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 17,334 | 19,869 | 44,483 | 0 | 0 |
| share issue | |||||
| interest | |||||
| cash flow from financing | |||||
| cash and cash equivalents | |||||
| cash | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 |
carcinotech ltd Credit Report and Business Information
Carcinotech Ltd Competitor Analysis
Perform a competitor analysis for carcinotech ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in EH25 area or any other competitors across 12 key performance metrics.
carcinotech ltd Ownership
CARCINOTECH LTD group structure
Carcinotech Ltd has no subsidiary companies.
Ultimate parent company
CARCINOTECH LTD
SC604026
carcinotech ltd directors
Carcinotech Ltd currently has 5 directors. The longest serving directors include Ms Ishani Malhotra (Jul 2018) and Mr Albert Nicholl (Oct 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Ishani Malhotra | United Kingdom | 30 years | Jul 2018 | - | Director |
| Mr Albert Nicholl | England | 63 years | Oct 2020 | - | Director |
| Mr Albert Nicholl | United Kingdom | 63 years | Oct 2020 | - | Director |
| Dr Ian Waddell | Scotland | 61 years | May 2022 | - | Director |
| Dr Lorna Ewart | Scotland | 50 years | Jun 2024 | - | Director |
P&L
September 2023turnover
854k
-46%
operating profit
-531.9k
0%
gross margin
25.6%
-17.18%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
522.2k
-0.5%
total assets
807.5k
-0.35%
cash
0
0%
net assets
Total assets minus all liabilities
carcinotech ltd company details
company number
SC604026
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
July 2018
age
6
incorporated
UK
accounts
Micro-Entity Accounts
ultimate parent company
previous names
N/A
last accounts submitted
September 2023
address
roslin innovation centre, easter bush campus, edinburgh, midlothian, EH25 9RG
accountant
-
auditor
-
carcinotech ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to carcinotech ltd.
carcinotech ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
